View of Therapeutic Efficacy of Intravitreal Bevacizumab (Avastin)® in Patients with Parafoveal Telangiectasia Type II Complicated by Choroidal Neovascular Membrane and/or Cystoid Macular Edema

Return to Article Details Therapeutic Efficacy of Intravitreal Bevacizumab (Avastin)® in Patients with Parafoveal Telangiectasia Type II Complicated by Choroidal Neovascular Membrane and/or Cystoid Macular Edema Download Download PDF